The Board of Directors announced Consolidated Financial Statements of 2024 Q3
1.Date of submission to the board of directors or approval by the board of directors:2024/10/30
2.Date of approval by the audit committee:2024/10/30
3.Start and end dates of financial reports or annual self-assessed financial information of the reporting period:2024/01/01~2024/09/30
4.Operating revenue accumulated from 1/1 to end of the period(thousand NTD):41,089,882
5.Gross profit (loss) from operations accumulated from 1/1 to end of the period (thousand NTD):5,664,133
6.Net operating income (loss) accumulated from 1/1 to end of the period(thousand NTD):2,984,363
7.Profit (loss) before tax accumulated from 1/1 to end of the period(thousand NTD):3,561,532
8.Profit (loss) accumulated from 1/1 to end of the period(thousand NTD):2,747,031
9.Profit (loss) during the period attributable to owners of parent accumulated from 1/1 to end of the period (thousand NTD):2,732,269
10.Basic earnings (loss) per share accumulated from 1/1 to end of the period (NTD):14.45
11.Total assets end of the period (thousand NTD):35,775,011
12.Total liabilities end of the period(thousand NTD):18,767,927
13.Equity attributable to owners of parent end of the period (thousand NTD):16,789,650
Share

- Co-Founder of TOPCO Scientific
Dr. J.W. Kuo
